Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study the efficacy and safety of AMG 073 in patients with
kidney failure who are being treated with hemodialysis or peritoneal dialysis and who also
have secondary hyperparathyroidism (HPT).